<DOC>
	<DOCNO>NCT01604746</DOCNO>
	<brief_summary>The purpose study verify long-term safety 2.5 µg , adjuvanted ( aluminium hydroxide ) dose Ross River Virus ( RRV ) vaccine .</brief_summary>
	<brief_title>Additional 6-Month Safety Follow-up After Completion Precursor Study 880801</brief_title>
	<detailed_description />
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects participate precursor Study 880801 meet follow criterion : Subject receive 3 RRV vaccination Study 880801 Subject complete Visit 6 Study 880801 Subject , applicable , subject´s parent ( ) /legal guardian ( ) , understand nature study procedure , agree provision provide write informed consent prior study entry Subject provide write assent accord his/her age , applicable Subject participate another clinical study Study 880801 involve investigational product ( IP ) investigational device within 30 day prior enrollment schedule participate another clinical study involve IP investigational device course study</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>